 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
oxaliplatin
 
Attending: ___.
 
Chief Complaint:
Oxaliplatin Desensitization
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
___ PMH of rectal adenocarcinoma (metastatic to the liver and
lungs), admitted for scheduled q2week cycle
of oxaliplatin desensitization (w/ ___ the day 
after).

Her C4D1 oxaliplatin infusion was aborted on ___ due to
hives one hour after infusion, and she had confirmed positive
allergy skin testing to oxaliplatin on ___. Her last cycle was
on ___, which she tolerated well. 

On arrival to the floor, patient is without acute complaint. She
noted that she was without pain, discomfort, fever, chills.  She
noted that she is eating a normal diet and is voiding/stooling
without any difficulty.  Denied any allergic symptoms such as
rash, abnormal throat sensation, hives, shortness of breath.

Son ___ was at bedside and provided ___ translation as per
patient's request. 

 
Past Medical History:
Ms. ___ first started noticing some unintentional weight loss
over the past 3 months. She recently noticed some blood in her
stool and presented to her PCP at ___ (Dr. ___ on ___. She underwent colonoscopy by Dr.
___ on ___ which yielded a large lesion in the rectum. Biopsy
was taken and is positive for low grade adenocarcinoma. She was
then referred to ___ for further workup. A CT torso on ___ was
performed and showed multiple large liver mets and a 2 cm lung
nodule concerning for metastasis. An MRI pelvis on ___ was
unable to be completed due to the presence of an IUD.

- ___ C1D1 FOLFOX
- ___ C2D1 FOLFOX + Neulasta (no ___ due to neutropenia)
- ___ CT torso shows decrease in pulmonary nodules and
primary rectal mass, stable liver mets
- ___ C3D1 FOLFOX7 + Avastin
- ___ C4D1 FOLFOX7 + Avastin, D1 oxaliplatin aborted due to
allergic reaction, D15 delayed due to need for desensitization.
- ___ CT torso shows decrease in primary tumor and liver
mets
- ___ C5D1 FOLFOX7 + Avastin with 3 bag oxaliplatin
desensitization
- ___ C6D1 FOLFOX7 + Avastin with 3 bag oxaliplatin
desensitization
- ___ CT torso show stable disease
- ___ C7D1 FOLFOX7 + Avastin with 3 bag oxaliplatin
desensitization
- ___ C8D1 FOLFOX7 + Avastin with 3 bag oxaliplatin
desensitization
- ___ C9D1 FOLFOX7 + Avastin with 3 bag oxaliplatin
desensitization
- ___ C10D1 FOLFOX7 + Avastin with 3 bag oxaliplatin
desensitization
- ___ C11D1 FOLFOX7 + Avastin with 3 bag oxaliplatin
desensitization
- ___ CT torso shows minimal increase of RLL nodule, stable
metastatic disease otherwise
- ___ C12D1 FOLFOX7 + Avasitin with 3 bag oxaliplatin
desensitization
 
PAST MEDICAL HISTORY: 
- Metastatic rectal cancer, as above
- PPD Positive
- Left Breast Fibroadenoma
- Vitamin D Deficiency

 
Social History:
___
Family History:
Denies any history of GI or other malignancies
 
Physical Exam:
ADMISSION/DISCHARGE PHYSICAL EXAM:  
GENERAL: Pleasant, lying in bed comfortably, son ___ at bedside
EYES: Anicteric sclerea, PERLLA
HEENT: OP clear, MMM, poor dentition
CARDIOVASCULAR: Regular rate and rhythm, no murmurs, rubs, or
gallops
RESPIRATORY: Appears in no respiratory distress, clear to
auscultation bilaterally, no crackles, wheezes, or rhonchi
GASTROINTESTINAL: Normal bowel sounds; nondistended; soft,
nontender without rebound or guarding
MUSKULOSKELATAL: Warm, well perfused extremities without lower
extremity edema; Normal bulk 
NEURO: Alert, oriented x3, motor and sensory function grossly
intact
SKIN: No significant rashes
PSYCH: normal mood/judgement/insight
 
Pertinent Results:
No Labs/Micro/Imaging
 
Brief Hospital Course:
___ PMH of rectal adenocarcinoma (metastatic to the liver and
lungs), admitted for scheduled q2week cycle
of oxaliplatin desensitization (w/ ___ the day 
after), was on 3 bag oxaliplatin intermediate desensitization 
protocol previously, now down to 2 bag protocol which she 
tolerated well without incident. 

Transitional Issues: 
1. Follow up in clinic as scheduled on ___ for chemotherapy
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Cetirizine 10 mg PO AS DIRECTED 
2. Docusate Sodium 100 mg PO BID 
3. Ondansetron 8 mg PO Q8H:PRN nausea/vomiting 
4. Prochlorperazine 10 mg PO Q6H:PRN nausea/vomiting 

 
Discharge Medications:
1.  Cetirizine 10 mg PO AS DIRECTED  
2.  Docusate Sodium 100 mg PO BID  
3.  Ondansetron 8 mg PO Q8H:PRN nausea/vomiting  
4.  Prochlorperazine 10 mg PO Q6H:PRN nausea/vomiting  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
#oxaliplatin allergy requiring desensitization
#metastatic rectal adenocarcinoma 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure taking care of you at ___ 
___. You were admitted for you scheduled 
desensitization dose of the oxaliplatin chemotherapy. You 
tolerated the treatment well, and will need to follow up in 
clinic tomorrow for the remainder of your treatment. 

Sincerely,
Your ___ Care Team
 
Followup Instructions:
___
